Petauri Acquires Franklin Pharmaceutical Consulting
October 10, 2026
Petauri acquired Franklin Pharmaceutical Consulting (FPC), adding its health economics and outcomes research, real-world evidence, and market access capabilities to Petauri Evidence. FPC founder Meg Franklin will serve as President of Petauri Evidence US, and the combined platform aims to connect evidence planning and generation with value communication and commercialization.
- Buyers
- Petauri
- Targets
- Franklin Pharmaceutical Consulting
- Platforms
- Petauri Evidence
- Industry
- Consulting
- Location
- North Carolina, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Petauri Acquires Artia Solutions to Expand Medicaid Market Access Capabilities
July 15, 2025
Healthcare Services
Petauri, a purpose-built pharmaceutical services platform backed by Oak Hill Capital, has acquired Artia Solutions, a Medicaid market access consultancy founded in 2005. The deal adds deep state Medicaid policy and reimbursement expertise to Petauri's platform, strengthening its public payer capabilities and end-to-end market access offerings for biopharma clients.
-
Petauri Acquires Formulary Insights
November 13, 2024
Healthcare Services
Petauri, a PE‑backed pharmaceutical services platform based in Nashville, has acquired Formulary Insights and merged the business into Petauri Advisors to expand its market access research and strategy capabilities. The acquisition broadens Petauri’s payer and market access offerings for biopharmaceutical clients and is supported by Oak Hill Capital, which is backing the platform with a multi‑hundred million dollar commitment.
-
Petauri Acquires Bluprint Oncology, Cogency, Verascity and Blendworks from Brightly Network
August 14, 2024
Healthcare Services
Petauri, the Oak Hill Capital–backed pharmaceutical services platform, acquired four U.S.-based medical communications agencies — Bluprint Oncology, Cogency, Verascity, and Blendworks — from the Brightly Network. The additions expand Petauri Advance's oncology, hematology and rare-disease communications capabilities and increase the platform's depth in medical and commercial strategy, engagement, and education.
-
Petauri Acquires FORCE Communications
February 14, 2024
Healthcare Services
Petauri, a pharmaceutical services platform backed by Oak Hill Capital, has acquired FORCE Communications and its three independent agencies — DRIVE, MOMENTUM, and PROPEL. The add-on expands Petauri's scientific communications and medical education capabilities as the platform continues to build scale in medical affairs, market access, patient services, and data and analytics.
-
Petauri Health (Oak Hill) Acquires The Kinetix Group
June 13, 2023
Healthcare Services
Petauri Health, a pharmaceutical commercialization platform formed by Oak Hill Capital, has acquired The Kinetix Group (TKG), a New York–based market access, access marketing, and medical affairs agency. The Kinetix founders will remain in leadership roles as TKG becomes the inaugural add-on to the Petauri platform, expanding the platform's market access, medical affairs, and real-world evidence capabilities.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.